Evaluation of 177Lu-CHX-A''-DTPA-Bevacizumab as a radioimmunotherapy agent targeting VEGF expressing cancers

No Thumbnail Available

Click here to download

0816.htm (3.97 KB)

Date

2016

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Vascular Endothelial Growth Factor(VEGF), Bevacizumab, 177Lu-CHX-A"-DTPA-Bevacizumab, Melanoma

Source

Applied Radiation and Isotopes, 2016. Vol. 114: pp. 196-201

URI

http://hdl.handle.net/123456789/14126

Collections

2016